Virtus ETF Advisers’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,582
| Closed | -$69.2K | – | 597 |
|
|
2024
Q4 | $69.2K | Sell |
1,582
-739
| -32% | -$32.3K | 0.03% | 381 |
|
|
2024
Q3 | $105K | Buy |
2,321
+43
| +2% | +$1.95K | 0.05% | 371 |
|
|
2024
Q2 | $88.4K | Sell |
2,278
-1,033
| -31% | -$40.1K | 0.04% | 368 |
|
|
2024
Q1 | $107K | Sell |
3,311
-229
| -6% | -$7.38K | 0.06% | 355 |
|
|
2023
Q4 | $102K | Sell |
3,540
-376
| -10% | -$10.8K | 0.06% | 351 |
|
|
2023
Q3 | $108K | Sell |
3,916
-390
| -9% | -$10.8K | 0.07% | 326 |
|
|
2023
Q2 | $115K | Buy |
4,306
+137
| +3% | +$3.67K | 0.07% | 332 |
|
|
2023
Q1 | $90.3K | Sell |
4,169
-1,602
| -28% | -$34.7K | 0.05% | 363 |
|
|
2022
Q4 | $137K | Sell |
5,771
-443
| -7% | -$10.6K | 0.07% | 372 |
|
|
2022
Q3 | $123K | Buy |
6,214
+45
| +0.7% | +$891 | 0.05% | 393 |
|
|
2022
Q2 | $120K | Sell |
6,169
-206
| -3% | -$4.01K | 0.04% | 383 |
|
|
2022
Q1 | $163K | Sell |
6,375
-371
| -5% | -$9.49K | 0.07% | 215 |
|
|
2021
Q4 | $170K | Buy |
6,746
+596
| +10% | +$15K | 0.06% | 287 |
|
|
2021
Q3 | $169K | Sell |
6,150
-321
| -5% | -$8.82K | 0.07% | 312 |
|
|
2021
Q2 | $205K | Sell |
6,471
-454
| -7% | -$14.4K | 0.08% | 329 |
|
|
2021
Q1 | $318K | Buy |
6,925
+120
| +2% | +$5.51K | 0.13% | 229 |
|
|
2020
Q4 | $269K | Sell |
6,805
-1,733
| -20% | -$68.5K | 0.11% | 281 |
|
|
2020
Q3 | $297K | Sell |
8,538
-1,163
| -12% | -$40.5K | 0.16% | 225 |
|
|
2020
Q2 | $306K | Buy |
+9,701
| New | +$306K | 0.14% | 300 |
|